ADTRAN, Inc.

ADTN Q2 2026

Reported: 2026-08-06

Shares dropped 10.7% as investors reacted negatively to supply-chain-driven shipment delays and unfavorable product mix that pressured margins and dragged revenue below guidance.

Key takeaways

Revenue totaled $281.1 million, up 6.1% year-over-year, but below original guidance due to a delayed project from a key customer and supply constraints.
Optical Networking grew 22% year-over-year, driving broad-based demand across service provider, enterprise, government, and cloud segments.
Access & Aggregation Solutions revenue declined 5% year-over-year, impacted by customer timing shifts outside the U.S., partially offset by 13% growth in U.S. orders.
Gross margin contracted to 40.7% from 41.4% a year ago and 43% in the prior quarter due to mix headwinds and elevated product costs amid supply shortages.
Non-GAAP operating margin improved slightly year-over-year to 3.8% but fell sharply sequentially from 6.9%, reflecting margin compression pressures.

View recap

AdaptHealth Corp.

AHCO Q2 2026

Reported: 2026-08-06

AdaptHealth's shares plunged 40% following a disappointing outlook driven by significant margin compression and operational challenges related to its West Coast capitated contract, which is weighing heavily on near-term profitability.

Key takeaways

Q2 net revenue from continuing operations grew 12.7% YoY to $740.3 million, driven by 15.9% organic growth.
West Coast capitated contract added 10.7 points to organic growth but resulted in elevated costs and inefficiencies.
Adjusted EBITDA margin contracted to 17.8%, impacted by $40 million in expected profitability headwinds from the West Coast contract.
Elevated sleep resupply and enteral volumes created transitory and structural cost pressures.
Management is implementing operational fixes including workflow alignment, technology adoption, and delivery model changes to stabilize margins.

View recap

Astera Labs, Inc. Common Stock

ALAB Q2 2026

Reported: 2026-08-06

Astera Labs shares edged down 0.8% following Q2 results that showed solid sequential growth but failed to excite investors amid cautious outlook signals and margin pressures.

Key takeaways

Q2 revenue reached $392.4 million, up 27% sequentially and 104% year-over-year, reflecting broad-based demand across their product portfolio.
PCIe 6 products comprised over 50% of total revenue, with significant growth in Scorpio AI fabric switches and Aries retimers.
Scorpio X-Series volume production began ahead of schedule, with expectations to become the largest product family in Q3.
Taurus smart cable modules launched in pre-production, supporting next-gen Ethernet with new architecture enabling smart swap flexibility.
While growth drivers remain, investors appear tempered by margin compression and cautious guidance around scaling high ASP products and the evolving AI infrastructure market.

View recap

Advanced Micro Devices, Inc.

AMD Q2 2026

Reported: 2026-08-06

AMD shares declined 0.5% following Q2 results that showed continued strong growth but raised concerns about margin leverage and the sustainability of rapid expansion, reflecting cautious investor sentiment despite record revenue.

Key takeaways

Revenue rose 50% year-over-year to $11.5 billion, led by a doubling in data center sales to $6.7 billion, now 58% of total revenue.
Data center growth was driven by EPYC CPUs and Instinct accelerators, with record cloud and enterprise server CPU sales, exceeding prior outlook.
CEO highlighted the upcoming sixth-gen EPYC Venice CPUs and new Helios AI platform, underscoring ongoing product innovation and customer demand.
Investor caution likely stems from margin pressure as the company invests heavily in AI platforms and partnerships, including multi-gigawatt GPU deployments.
Outlook and commentary suggested continued growth but with tempered expectations around the scale and timing of ramping new technologies.

View recap

AMETEK, Inc.

AME Q2 2026

Reported: 2026-08-06

AMETEK’s Q2 performance and outlook exceeded expectations, driving a 4.5% stock gain as the company reported record sales, strong margin expansion, and broad-based orders growth that underpinned its raised full-year guidance.

Key takeaways

Q2 sales hit a record $2.04 billion, up 15% YoY, with 10% organic growth and a 5% contribution from acquisitions.
Orders surged 28% overall (25% organic), creating a record backlog of $4.11 billion, reflecting sustained strong demand across all divisions.
Operating income rose 18% to $544 million, with core margins expanding 110 basis points to 27.1%.
Free cash flow grew 37% to $452 million, converting at 111% of net income, indicative of disciplined working capital management.
Both Electronic Instruments Group and Electromechanical Group posted substantial sales and margin improvements, with EMG core margins up 290 basis points to 26.2%.

View recap

Amgen Inc.

AMGN Q2 2026

Reported: 2026-08-06

Amgen’s shares rose 7.6% in response to better-than-expected growth across its key product portfolio, led by double-digit sales increases in six core growth drivers. The market rewarded the company’s clear acceleration in volume demand and margin performance despite ongoing biosimilar pressures.

Key takeaways

Total revenues surpassed $10 billion, up 10% year-over-year, powered by 22 products delivering double-digit growth.
Six key growth drivers expanded 26% collectively, representing nearly 70% of total product sales, with standout performers including Repatha (+37%), EVENITY (+38%), TEZSPIRE (+42%), Rare Disease (+21%), Innovative Oncology (+18%), and Biosimilars (+29%).
Repatha sales reached $953 million with new-to-brand prescriptions growing 50% year-over-year in the U.S., supported by broad access and strong clinical data.
Margin performance remained solid despite increased investment in innovation and ongoing competition from biosimilars, particularly impacting Prolia and XGEVA, which declined 33%.
Late-stage pipeline and technology investments continue advancing with a focus on expanding indications and geographic reach to sustain long-term durable growth.

View recap

Arista Networks, Inc.

ANET Q2 2026

Reported: 2026-08-06

Arista’s shares gained 6.7% following Q2 results, driven by strong AI-related product demand and continued innovation that outpaced concerns about persistent supply chain challenges.

Key takeaways

Revenue approached the $3 billion quarterly milestone, a significant growth trajectory compared to previous years.
AI fabrics traction grew considerably, expanding from 4–5 customers in 2024 to over 100 cumulatively, underscoring increasing adoption.
Innovations such as Smart System Upgrade (SSU), Multipath Reliable Connection (MRC), and enhanced Segment Routing (SRv6) strengthened competitive positioning in AI networking.
Supply chain constraints and component cost pressures remain an issue but are being actively managed with progress reported.
The expansive Scale-Across AI market opportunity, forecasted between $15 billion and $20 billion by 2030, positions Arista well for long-term growth.

View recap

Angel Oak Mortgage, Inc.

AOMR Q2 2026

Reported: 2026-08-06

Angel Oak Mortgage REIT’s shares inched up 1.3% post-earnings, reflecting a generally stable quarter with solid net interest income growth offset by unrealized mark-to-market losses; investors appeared to weigh the balance between ongoing portfolio discipline and cautious macroeconomic headwinds.

Key takeaways

GAAP net income rose to $3.4 million ($0.14 per diluted share) from $0.8 million ($0.03 per share) in Q2 2025, driven by healthy net interest income but partially offset by unrealized losses totaling $6 million across loan and derivative portfolios.
Net interest income increased 8% year-over-year to $10.7 million, supported by an 18% rise in interest income to $41.4 million, reflecting targeted asset purchases and lower financing costs.
The company repurchased $15 million in common equity at accretive levels and secured a 35 basis point reduction on its largest warehouse financing spread, actions expected to benefit future returns.
Loan purchases totaled $204 million with conservative credit metrics: 7.34% weighted average coupon, 70.5% CLTV, and a credit score of 759, indicating continued credit discipline.
Operating expenses increased slightly to $3.2 million (ex-stock comp), attributed to higher loan diligence fees tied to larger asset balances, with guidance to maintain stable expense levels going forward.

View recap

Apollo Global Management, Inc.

APO Q2 2026

Reported: 2026-08-06

Apollo’s Q2 earnings prompted a muted market response (+0.2%), reflecting a largely in-line performance without meaningful surprises or setbacks. While the firm highlights record fee-related and spread-related earnings alongside strong origination and capital formation, the stock’s flat reaction suggests investors were not significantly moved by the results or underlying outlook.

Key takeaways

Fee-Related Earnings (FRE) hit a record $785 million, up 25% year-over-year and 8% sequentially.
Spread-Related Earnings (SRE) reached a record $877 million, growing 11% year-over-year and 5% from the prior quarter.
Origination remained robust at $74 billion, though several large announced deals will impact future periods rather than Q2 results.
Capital formation set a quarterly record at $60 billion, supported by strong organic inflows across asset management and Athene.
Management emphasized strategic initiatives like estimated daily NAV and the ICE joint venture to expand investor access and improve transparency, positioning for future growth outside of current private market structures.

View recap

Avista Corporation

AVA Q2 2026

Reported: 2026-08-06

Shares declined 3.1% after Avista’s earnings as investors reacted negatively to uncertainties surrounding wildfire-related infrastructure damage and a cautious outlook on future capital projects, particularly the pause and potential scaling back of a 500-megawatt data center buildout.

Key takeaways

Wildfire damage in Spokane has caused ongoing electricity and natural gas outages impacting roughly 7,300 electric customers and 5,300 gas customers, with key transmission lines still under repair.
The full financial impact of wildfire-related damage remains unclear, with cost recovery and insurance treatment still being assessed; securitization of wildfire costs is considered unlikely at this stage.
Management reiterated strong commitment to system reliability and customer affordability but confirmed a pause on the large data center project, removing the 500-megawatt project as upside to the capital plan.
Conversations with regulators and community stakeholders continue, emphasizing the need for net benefit and protections for existing customers before resuming significant new load growth.
The ongoing dynamic situation with wildfires and cautious guidance on capital expansion weighed on investor sentiment, reflecting concerns over near-term operational and regulatory challenges.

View recap

BB Seguridade Participacoes S.A.

BBSE3.SA Q2 2026

Reported: 2026-08-06

The stock edged up modestly by 0.7% as the quarter showed a mostly stable operational performance with mixed income components, reflecting limited investor enthusiasm amid modest growth and some headwinds from investment income volatility.

Key takeaways

Recurring net managerial income rose 3.2% to BRL 4.4 billion year-over-year for the first half of 2026.
Net operating income after taxes increased by BRL 0.3 billion, supported by a lower loss ratio in insurance and higher management fees.
Net investment income after taxes grew over 16% to BRL 909.1 million, driven by a favorable financial environment despite some mark-to-market accounting losses.
Retained premiums in insurance remained stable at BRL 7 billion, but agricultural insurance premiums declined, partially offsetting gains.
Brasilprev reserves expanded 10.6% to BRL 496.5 billion, with a positive net inflow of BRL 2.8 billion despite challenging market competition.

View recap

BellRing Brands, Inc.

BRBR Q3 2026

Reported: 2026-08-06

Shares declined 2.6% as investors digested mixed results marked by margin compression and a cautious outlook despite sales growth. Rising costs, inventory headwinds, and ongoing margin pressure tempered enthusiasm for near-term profitability.

Key takeaways

Net sales and consumption were above expectations, supported by Premier Protein and Dymatize brand strength.
Adjusted EBITDA margins fell below guidance owing to inventory-related challenges and elevated freight expenses.
Management announced double-digit price increases effective fiscal 2027 Q1 to offset persistent inflationary pressures, anticipating volume elasticity just over 1.
Efforts to diversify channel mix through innovation, convenience channel expansion, and new product launches like Premier Protein Sparkling Soda are underway.
Fiscal 2027 guidance incorporates sustained cost pressures, reflecting a cautious outlook on margin recovery and profit trajectory.

View recap

Black Stone Minerals, L.P.

BSM Q2 2026

Reported: 2026-08-06

Shares of Black Stone Minerals declined 1.1% following the Q2 report as investors digested a modest production decline and mixed production trends, despite higher oil prices and active development. The market appears cautious given the sequential production dip and uneven volume performance across key gas-focused areas.

Key takeaways

Quarterly mineral royalty production averaged 32.5 MBoe/d, down from the prior quarter due primarily to lower natural gas volumes in the Haynesville.
Average realized price per Boe rose 7% sequentially to $37.82, driven by stronger oil prices, which partially offset volume declines.
Leasing and asset management initiatives generated about $19.5 million in revenue, including $13 million from lease bonuses plus $6.5 million in lease refund collections.
Development activity continues with rigs operating in Shelby Trough and Haynesville, including operator progress by Adamas, Revenant, and new activity from Caturus.
Production decline from Q1 and ongoing variability in gas volumes, despite positive pricing, contribute to cautious near-term outlook reflected in subdued share reaction.

View recap

BWX Technologies, Inc.

BWXT Q2 2026

Reported: 2026-08-06

BWXT's shares rose modestly by 2.2% post-earnings, reflecting a generally in-line quarter that showed steady backlog growth and operational execution, but without a meaningful catalyst to drive a stronger market response.

Key takeaways

Revenue increased 18%, supported by 9% organic growth and continued demand in nuclear solutions across national security and commercial power markets.
Adjusted EBITDA grew 7%, and adjusted EPS rose 5%, reflecting solid but not accelerating profitability improvements.
Backlog stood at $8.4 billion, up 40% year-over-year, though sequentially down slightly due to normal timing of large contract awards.
Government Operations segment delivered strong margins supported by productivity gains and benefited from an updated Navy shipbuilding plan enhancing production stability.
BWXT continues to invest in U.S. commercial manufacturing capabilities, including the recent acquisition of Precision Components Group and potential expansion projects supported by government awards.

View recap

Certara, Inc.

CERT Q2 2026

Reported: 2026-08-06

Shares declined 2.1% following Certara’s Q2 report as investors appeared unimpressed by modest revenue growth, persistent service revenue weakness, and cautious full-year guidance despite ongoing transformation efforts.

Key takeaways

Revenue grew 1% in Q2, with software up 4% but services down 3%, reflecting ongoing challenges in the services segment.
Trailing 12-month software bookings rose 7% (excluding Chemaxon), showing some momentum improvement from prior periods.
Services bookings remained sluggish with a 1.07 book-to-bill ratio, partly impacted by divestiture of regulatory and medical writing businesses.
The company reaffirmed full-year revenue growth guidance of 0% to 4%, signaling a cautious outlook.
Cost reduction efforts, including a 5% workforce reduction, are expected to generate $13 million in run-rate savings to support innovation investments.

View recap

Cipher Mining Inc. Common Stock

CIFR Q2 2026

Reported: 2026-08-06

Cipher Digital’s stock dropped 22.5% on earnings, reflecting investor disappointment primarily driven by a cautious outlook and a deceleration in near-term cash flow realization despite execution milestones.

Key takeaways

Early delivery of Black Pearl capacity occurred two months ahead of schedule, and rental payments have commenced, but near-term cash flow visibility remains limited.
The company announced an $810 million bond issuance for the Stingray site at a 6% coupon, priced tighter than previous bonds; however, broader credit market spread widening signals underlying market concerns.
Pipeline expanded with a new 1.1 gigawatt site (Apollo) and a 200-megawatt expansion at Stingray, but the majority of 5.3 gigawatts remains in future developments with longer-term visibility.
Average annualized net operating income from current leases is expected at approximately $793 million starting October 2026, indicating cash flows are still in ramp-up phase.
Management emphasized operational execution and construction acceleration, but cautious tone on timing and monetization likely contributed to negative market reaction.

View recap

The Clorox Company

CLX Q4 2026

Reported: 2026-08-06

Shares rallied 9.6% following the quarterly report, driven by encouraging sequential market share gains and signs of stabilization in consumer demand despite ongoing category softness and macroeconomic uncertainty.

Key takeaways

The company delivered nearly flat consumption exiting Q4, improving sequentially each quarter through the fiscal year.
Home Care posted its eighth consecutive quarter of market share growth, while Pro and International segments also showed share gains.
Key brand turnarounds included Glad and Hidden Valley Ranch, supported by innovation, pricing, and marketing to offset soft category trends.
Management flagged timing-related headwinds in Q1, particularly with the grilling season affecting Kingsford, dampening near-term growth prospects.
Despite decelerating category growth and cautious outlook, continued brand investments and operational improvements underpin confidence in long-term value creation.

View recap

Cummins Inc.

CMI Q2 2026

Reported: 2026-08-06

Cummins' stock was essentially unchanged following second quarter results, reflecting mixed performance with growth in sales offset by margin pressures and cautious execution risks amid regulatory transitions.

Key takeaways

Q2 sales reached a record $9.5 billion, up 9% year-over-year, driven by higher global demand in power generation and international construction markets.
EBITDA grew to $1.7 billion but margins contracted to 17.5% from 18.4% a year ago, impacted by tariffs and increased variable compensation expenses.
North American revenues increased 8%, despite a 4% decline in heavy-duty truck industry production; Cummins’ heavy-duty unit sales rose slightly by 2%.
Power generation sales in North America surged 19%, supported by expanding data center demand and recently added manufacturing capacity.
International revenue increased 12%, with China delivering a strong 30% sales growth fueled by data center expansion and robust truck markets.

View recap

Coupang, Inc.

CPNG Q2 2026

Reported: 2026-08-06

Coupang's shares fell 2.6% following Q2 results as investors digested ongoing margin pressures from fixed costs and marketing spend aimed at customer reacquisition, alongside only moderate top-line growth amid recovery from last year's data incident.

Key takeaways

Reported revenue grew 10% year-over-year in constant currency, matching guidance but reflecting mixed customer behavior post-incident.
Product commerce revenue increased 8% year-over-year; underlying spend growth for returning cohorts rose around 16%, with a non-returning minority still weighing on overall growth.
Adjusted EBITDA margin remained within guided range but was pressured by capacity costs aligned to higher expected demand and increased marketing investment.
Management emphasized a strategic choice to maintain capacity and marketing spend to support long-term growth despite short-term margin headwinds.
The recovery and normalization of growth and margins are expected to extend into next year, as the company laps disrupted periods and recovers volume-related cost savings.

View recap

Capital Southwest Corporation

CSWC Q1 2027

Reported: 2026-08-06

Capital Southwest’s shares rose modestly by 2.0% following the quarter, reflecting a generally steady performance without clear upside surprises or significant disappointments driving the move.

Key takeaways

Pretax net investment income was $0.57 per share, supported by consistent recurring earnings.
Total new commitments reached $222 million, including investments in 11 new and 16 existing portfolio companies.
Weighted average yield on the debt portfolio increased slightly to 10.9%, driven by higher portfolio spreads despite a tighter credit environment.
The portfolio grew 24% year-over-year to $2 billion, maintaining strong discipline with 99% first lien senior secured loans.
Raised $64 million in gross equity proceeds through the ATM program, benefitting from a favorable price-to-book multiple relative to peers.

View recap

Crexendo, Inc.

CXDO Q2 2026

Reported: 2026-08-06

Shares fell 8.2% following the Q2 report as investors reacted negatively to signs of deceleration in organic growth and cautious outlook cues, despite strong overall revenue expansion driven by acquisitions.

Key takeaways

Total revenue grew 49% year-over-year to $24.6 million, largely fueled by the ESI acquisition.
Organic revenue growth slowed to 7% year-over-year for the quarter, marking a deceleration from prior trends.
Service revenue, underscored by the acquisition, rose 78% to $14.9 million; Software Solutions revenue was up 5% to $7.3 million with a 70% gross margin.
The company maintained GAAP profitability with $1.1 million net income and generated $4.8 million in operating cash flow year-to-date.
Though management expressed enthusiasm about AI initiatives and platform enhancements, AI revenues remain immaterial and the next major software release is projected for Q2 2027.

View recap

Danaos Corporation

DAC Q2 2026

Reported: 2026-08-06

Danaos shares fell 2.4% following Q2 results as container segment revenue stagnated and operating costs rose, offsetting strong Dry Bulk performance and leaving investors cautious despite a solid backlog.

Key takeaways

Adjusted net income increased 15% year-over-year to $133.1 million, driven mainly by Dry Bulk segment gains.
Dry Bulk revenue grew 57% to $35.7 million, with Capesize rates rising from $18,000 to $30,400 per day, pushing Dry Bulk adjusted EBITDA from $5.9 million to $18.8 million.
Container vessel revenue was essentially flat, declining by $0.8 million to $237.9 million, impacted by a $3.4 million reduction in noncash revenue recognition and $1.2 million higher off-hire charges.
Vessel operating costs were stable in aggregate but daily operating costs declined slightly to $7,416 per vessel per day.
G&A expenses increased $3.7 million to $14.9 million, primarily due to higher management fees and corporate overhead.

View recap

3D Systems Corporation

DDD Q2 2026

Reported: 2026-08-06

3D Systems’ stock surged 26.1% following Q2 results, driven by impressive printer sales growth and robust demand across multiple high-value markets including aerospace, healthcare, and dental, highlighting strong operational execution amid a refreshed product portfolio.

Key takeaways

Printer sales increased over 45% year-over-year, fueled by strong demand for the DMP 350 metal printer, SLA 825 polymer platform, and NextDent 300 denture system.
Healthcare segment led revenue growth, supported by medtech and dental markets maintaining solid momentum.
Industrial segment revenue declined modestly year-over-year as legacy systems were replaced by newer platforms, though key verticals like aerospace, defense, and data center infrastructure delivered strong double-digit growth.
Metal printing systems (DMP 350 and SLA 825) saw exceptional growth of approximately 90% and 125%, respectively, reflecting accelerating adoption of additive manufacturing in metal component production.
The company is expanding internal metal parts production capacity to capitalize on rising demand, particularly from aerospace customers benefiting from increased launch cadence and advanced rocket engine manufacturing.

View recap

DigitalOcean Holdings, Inc.

DOCN Q2 2026

Reported: 2026-08-06

DigitalOcean shares declined 2.1% following Q2 results that showed solid revenue growth and product traction but raised investor concerns likely tied to cautious commentary on supply constraints and a tempered outlook despite management's upbeat narrative.

Key takeaways

Q2 revenue reached $281 million, up 29% year-over-year, marking an acceleration in top-line growth.
Adjusted EBITDA margin was 40%, with adjusted operating income margin at 24% and free cash flow margin at 17%, reflecting disciplined profitability.
AI customer ARR surged over 200% year-over-year to $234 million, driven primarily by inference services which grew nearly 800%.
Over 6,000 customers adopted the newly launched inference engine since late April, with token volume increasing 30x in 60 days.
Despite momentum, ongoing supply chain challenges and the need for responsible investment suggest cautious execution risks ahead; management raised full-year revenue growth outlook to ~30% but signaled a wait-and-see stance on 2027 guidance.

View recap

Domino's Pizza Group plc

DOM.L Q2 2026

Reported: 2026-08-06

Domino's shares rose 3.8% post-earnings as the company delivered positive like-for-like sales growth supported by the World Cup tailwind and a balanced contribution from the new chicken offering, alongside improving franchisee profitability and ongoing supply chain automation initiatives.

Key takeaways

Like-for-like sales remained positive every month this year, with some benefit from the World Cup but underlying momentum independent of the event.
The launch of chicken in February contributed incremental sales without cannibalizing pizza volumes, leading to larger average order sizes.
Franchisee profitability is on an improving trend compared to prior years, reflecting alignment with Domino’s focus on core strengths and operational execution.
Supply chain automation projects, including warehouse upgrades and route efficiencies, are expected to reduce labor costs starting in the second half of the year.
A revamped loyalty program is set for full launch in Q4, designed to increase frequency and customer retention, with franchisee economics in mind.

View recap

Duke Energy Corporation

DUK Q2 2026

Reported: 2026-08-06

Shares of Duke Energy declined modestly by 0.8% following the earnings announcement, reflecting investor caution despite stable execution and reaffirmed guidance, with concerns likely centered on limited near-term upside and cautious outlook around large-scale capital projects.

Key takeaways

Reported adjusted EPS of $1.43 for Q2, maintaining steady operational performance.
Reaffirmed full-year 2026 EPS guidance range of $6.55 to $6.80 and long-term growth target of 5% to 7% through 2030.
Recent regulatory settlements in North Carolina on rate cases offer constructive but modest ROE terms (9.8% allowed ROE with earnings sharing up to 10.3%).
Executing the largest regulated capital plan in the industry, deploying over $1 billion monthly to support growing demand and infrastructure upgrades.
Continued progress on generation build with 15 GW capacity targeted by 2031, while emphasizing the need for financial protections before pursuing new nuclear projects due to associated risks.

View recap

DaVita Inc.

DVA Q2 2026

Reported: 2026-08-06

Shares dropped 19.3% following DaVita’s Q2 report as investors reacted negatively to margin compression and a cautious outlook driven by lower sequential revenue per treatment and expected headwinds from declining ACA enrollment and phosphate binder reimbursement.

Key takeaways

Volume growth accelerated year-over-year, slightly surpassing expectations due to improvements in patient mortality.
Revenue per treatment declined sequentially, negatively impacted by a lower commercial mix from ACA enrollment declines and reduced contribution from phosphate binders.
Gross margin pressure emerged, partly reflecting the transition of phosphate binders into the Medicare dialysis bundle and reimbursement complexities.
Management highlighted support for upcoming CMS ESRD payment rule changes but acknowledged proposed Medicare base rate updates will likely trail industry cost inflation.
New dialysis therapies (expanded HD with medium cutoff dialyzers) were positioned as a future growth and clinical advancement opportunity but have yet to offset current financial headwinds.

View recap

Emerson Electric Co.

EMR Q3 2026

Reported: 2026-08-06

Emerson's stock rose 4.9% following a quarter that saw broad-based demand growth and margin expansion, driven primarily by impressive performance in Software & Systems and strong order momentum. The company raised full-year guidance, supported by solid sales growth, improved margins, and robust wins across key verticals.

Key takeaways

Underlying orders increased 7%, with Software & Systems leading at 10% growth and notable strength in semiconductor (+70%) and Test & Measurement (+19%).
Sales grew 6%, with remarkable growth in Test & Measurement and Ovation businesses, each up 23%.
Adjusted segment EBITDA margin expanded 140 basis points to 28.5%, reflecting operational leverage amid solid execution.
Adjusted EPS rose 13% to $1.71, exceeding the top of the guidance range; full-year adjusted EPS guidance raised to $6.55.
Project funnel expanded 8% to $12.4 billion, driven by a $450 million sequential increase in power and continued investments in LNG and grid modernization.

View recap

Enlight Renewable Energy Ltd

ENLT Q2 2026

Reported: 2026-08-06

Enlight’s shares edged down 0.4% post-earnings, reflecting a market stance that views the results as largely in line with expectations despite solid revenue and EBITDA gains. The absence of any notable positive catalyst or upward market reaction suggests investor caution amid a backdrop of stable but unspectacular execution.

Key takeaways

Revenues increased 55% year-over-year to $210 million, driven by new project contributions, tax benefits, higher generation, and favorable currency effects.
Adjusted EBITDA rose 67% to $160 million, supported by increased electricity sales and trading activity.
Net profit was $31 million; operating cash flow improved 34% to $84 million year-over-year.
The total project portfolio expanded by 4.6% to 43.1 factored gigawatts; safe harbor capacity reached 17.9 factored gigawatts.
Management raised 2026 guidance modestly (around 4% for revenues and 3.6% for adjusted EBITDA), reflecting confidence but without prompting a meaningful market re-rating.

View recap

Fidelity National Information Services, Inc.

FIS Q2 2026

Reported: 2026-08-06

Shares declined 4.3% as investors were disappointed by cautious outlook commentary and continued softness in Capital Markets, which grew at the low end of expectations despite strength in Banking.

Key takeaways

Revenue of $3.4 billion grew 5.3% on a pro forma basis, driven by a 6.1% increase in Banking and Payments at the high end of guidance.
Capital Markets segment grew 3.2%, coming in at the low end of the company’s outlook and prompting management’s acknowledgment of ongoing underperformance.
Adjusted EBITDA margins expanded by 113 basis points with 7.4% EBITDA growth, though margin improvement was overshadowed by segment disparities.
Free cash flow more than tripled year-over-year, leading to a $100 million increase in the full-year free cash flow outlook.
The Total Issuing Solutions acquisition is delivering on client wins and revenue growth, with 72% of that portfolio now contracted through 2029 and joint enterprise ACV growing 35% year-over-year.

View recap

Fresenius Medical Care AG & Co. KGaA

FME.DE Q2 2026

Reported: 2026-08-06

The stock dropped 7.9% following earnings as investors reacted negatively to the steeper-than-expected deceleration in U.S. same-market treatment growth, driven by operational execution issues impacting referrals and prompting a downward revision of full-year growth guidance for this key segment.

Key takeaways

U.S. same market treatment growth declined 0.9% in Q2, reflecting an operational miss in capturing referrals and a softening trend compared to Q1.
Management cut 2026 U.S. same market treatment growth guidance to roughly the Q2 level due to weaker than anticipated referral trends earlier in the year.
Despite ongoing margin improvements and EUR 67 million in sustainable cost savings from the FME25+ program, growth headwinds in the largest market overshadowed operational gains.
International markets delivered modest 0.8% same market treatment growth, providing limited offset to U.S. weakness.
Operational optimization efforts included exiting about 100 underperforming clinics and progress on infection reduction initiatives, but these appear insufficient to prevent investor disappointment.

View recap

Fresnillo plc

FRES.L Q2 2026

Reported: 2026-08-06

Shares rose 10% following results that benefitted from sharply higher precious metal prices and margin expansion, driving revenues and EBITDA well above expectations.

Key takeaways

Revenues increased notably, supported by elevated precious metal prices, with gross profit and EBITDA more than doubling year-over-year.
Gross margins improved significantly, contributing to a strong profitability profile despite some cost pressures.
Interim dividends were more than doubled compared to the prior year, reflecting confident cash flow generation and balance sheet strength.
Operational performance was largely in line with expectations, highlighted by a 47.6% increase in gold production at Fresnillo and 15% higher gold output at Ciénega.
Near-term challenges such as the Jarillas shaft connection at Saucito and maintenance at Herradura are expected to be temporary, with no changes to 2026 guidance.

View recap

Gulfport Energy Corporation Common Shares

GPOR Q2 2026

Reported: 2026-08-06

Gulfport Energy shares dropped 4.7% after the quarter, reflecting investor disappointment with a cautious outlook and indications of operational deceleration despite management’s optimistic framing around inventory growth and capital allocation.

Key takeaways

Production growth momentum appears to be slowing, raising concerns about the sustainability of recent gains.
Liquids volumes are expected to increase by over 50% in the second half, but investors are wary given the lack of concrete forward visibility.
The discretionary leasehold budget of $140 million aims to increase net Appalachia locations by ~20%, though the payoff timeline remains uncertain.
Management underscored capital allocation discipline, balancing drilling, leasehold acquisitions, and buybacks to optimize returns.
Although the balance sheet is described as strong, no new guidance was provided to reassure investors on near-term cash flow or margin stability.

View recap

Green Thumb Industries Inc.

GTII.CN Q2 2026

Reported: 2026-08-06

Green Thumb shares fell 7.7% following the earnings release, reflecting investor disappointment with modest revenue growth and ongoing price compression despite stable EBITDA margins and operational cash flow.

Key takeaways

Q2 revenue reached $307 million, up only 5% year-over-year, indicating ongoing deceleration amid a competitive and price-compressed market.
Normalized EBITDA was $84 million, representing about 28% of revenue, showing margin stability despite external pressures.
Operating cash flow was $29 million, signaling positive but limited cash generation relative to revenue growth.
Management highlighted progress on federal cannabis rescheduling and state regulatory advances, yet the company remains cautious on near-term growth dynamics.
Green Thumb repurchased approximately 8 million shares during the quarter at an average price just over $6, reducing share count by 13% since Q4 2023, signaling confidence in long-term value despite near-term headwinds.

View recap

W.W. Grainger, Inc.

GWW Q2 2026

Reported: 2026-08-06

Shares declined 6.3% following Grainger’s Q2 report as investors reacted negatively to a cautious outlook implied by margin pressures and mixed segment dynamics despite solid revenue growth.

Key takeaways

Total company sales grew 10.3% (13.7% organic daily constant currency) driven by volume growth and price across High-Touch and Endless Assortment segments.
Operating margin expanded 120 bps to 16.1%, but normalized margins excluding a 90-basis-point tariff refund tailwind were only in line with guidance.
High-Touch segment grew sales 11.9% (11.7% constant currency) with margin up 70 bps to 17.3%, though mix was less favorable due to increased lower-margin product volume and project spend.
Gross margin benefited from tariff refunds and exited U.K. operations, but was partially offset by private label cost pressures and unfavorable freight expense.
SG&A deleveraged slightly, impacted by higher marketing expenses and increased incentive compensation despite strong top-line growth.

View recap

Hamilton Lane Incorporated

HLNE Q1 2027

Reported: 2026-08-06

Investor enthusiasm lifted the stock by 6.2% following a quarter marked by strong fee-related revenue growth and solid asset growth, reflecting better-than-expected results in fee-earning AUM and margin expansion.

Key takeaways

Total asset footprint exceeded $1 trillion, up 8% year-over-year.
Assets Under Management (AUM) grew 4% year-over-year to $146 billion; Assets Under Advisement (AUA) increased 8% YoY to $914 billion.
Total management and advisory fees rose 21% year-over-year to $161 million; fee-related revenue increased 44% YoY to $236 million.
Fee-related earnings showed a 49% year-over-year improvement, reaching $124 million.
Blended fee rate expanded to 69 basis points, driven by a higher mix of specialized funds.

View recap

Harmony Biosciences Holdings, Inc.

HRMY Q2 2026

Reported: 2026-08-06

Investor optimism was driven by better-than-expected commercial execution, with WAKIX revenue surging 30% year-over-year and a reaffirmed full-year revenue guidance of $1 billion to $1.04 billion. Encouraging early data from the BP-205 orexin-2 agonist pipeline also added confidence.

Key takeaways

WAKIX net revenue hit a record $261.3 million in Q2, up 30% year-over-year and 21% sequentially after seasonal headwinds in Q1.
Full-year 2026 net revenue guidance reiterated at $1 billion to $1.04 billion, consistent with previous outlook.
Promising Phase I single ascending dose data for BP-205 support its potential as a best-in-class orexin-2 receptor agonist with once-daily dosing potential.
Multiple upcoming data catalysts for BP-205 expected over the next six months, including Phase II trials starting mid-2027.
Strong balance sheet with approximately $963 million in cash enables continued investment in pipeline and strategic business development opportunities.

View recap

HSBC Holdings plc

HSBA.L Q2 2026

Reported: 2026-08-06

HSBC’s shares dropped 5.4% following the earnings release, reflecting investor disappointment with cautious outlook signals and lack of meaningful upside in growth or margins despite steady operational progress.

Key takeaways

Group revenues rose 6% year-on-year for the half, reaching USD 19 billion in Q2 with profits before tax up 13% at USD 10.3 billion.
Return on tangible equity remained strong at an annualized 19.1% for the half and 19.5% in Q2, supporting ongoing profitability levels.
Loan growth was steady at USD 55 billion (6%) year-on-year, with deposit growth of USD 129 billion (8%), driven by Hong Kong and U.K. markets.
Wealth management fee income increased 18%, and wholesale transaction banking fees grew 4%, indicating solid progress in fee-generating segments.
While cost-saving initiatives exceed initial targets at USD 1.7 billion, the outlook lacks clear positive revision, prompting investor caution despite strategic execution updates.

View recap

IDEXX Laboratories, Inc.

IDXX Q2 2026

Reported: 2026-08-06

IDEXX outpaced expectations with solid revenue growth and margin expansion, driving a 3.0% stock gain despite headwinds in U.S. clinical visits and a decline in CAG Diagnostics instrument revenues.

Key takeaways

Q2 organic revenue grew 9%, led by 10.3% organic increase in CAG Diagnostics recurring revenues and 13% growth in Water business.
Operating margin expanded 110 basis points, supported by gross margin gains and favorable product costs.
EPS rose 15% on a comparable basis to $4.27, with updated full-year EPS guidance raised to $14.69–$14.94.
U.S. same-store clinical visits declined 1.3%, primarily due to softness in wellness visits, though non-wellness visits showed modest growth.
CAG Diagnostics instrument revenues dropped 20% organically as the company lapped prior-year launches, but instrument placements remained high quality with over 5,200 units placed.

View recap

Inspire Medical Systems, Inc.

INSP Q2 2026

Reported: 2026-08-06

Inspire Medical Systems shares surged 27.7% following Q2 results as the company raised full-year guidance on revenue, adjusted operating margin, and adjusted EPS, driven by improved coding clarity and reimbursement initiatives that buoyed investor confidence.

Key takeaways

Q2 adjusted operating income and positive cash flow came in ahead of expectations due to disciplined cost management.
Company highlighted improved prior authorization submissions and clearer coding guidance for the Inspire V system, reducing payer confusion.
CMS has proposed 12% and 15% increases in 2027 hospital outpatient and ASC reimbursement rates respectively for Inspire V procedures.
Despite a 4% proposed decrease in physician reimbursement, management is advancing efforts to secure a new Category 1 CPT code for a single lead Inspire system, with approval expected in September.
The new Project Horizon strategic growth plan aims to accelerate revenue growth by investing $30 million annually to optimize patient flow, organizational structure, and supply chain efficiencies.

View recap

Intapp Inc. Common Stock

INTA Q4 2026

Reported: 2026-08-06

Intapp’s shares jumped 10.7% after delivering cloud ARR growth that sustained a strong 29% year-over-year increase and maintaining healthy net revenue retention of approximately 123%, signaling investor confidence in the ongoing demand for its Firm AI and Celeste platforms.

Key takeaways

Cloud ARR grew 29% year-over-year in Q4, now making up 84% of total ARR, continuing a 20-quarter streak of growth above 25%.
Cloud net revenue retention remained solid at approximately 123%, indicating strong customer retention and expansion.
Celeste moved to general availability post-quarter and is already gaining traction among high-profile clients across legal, accounting, private capital, and investment banking sectors.
The Firm AI platform distinguishes Intapp by embedding firm-specific compliance and data workflows, enhancing competitive advantage in regulated industries.
Management highlighted an expanding pipeline and increasing use cases, supporting optimism around future adoption and revenue growth.

View recap

International Petroleum Corporation

IPCO.TO Q2 2026

Reported: 2026-08-06

Shares declined 6.7% as investors reacted unfavorably to the cautious outlook reflected in the company's full-year free cash flow guidance and a deceleration in margin improvement, despite stable production and capital spending.

Key takeaways

Production in Q2 matched guidance at 42,200 BOE/day, with full-year 2026 guidance maintained at 44,000 to 47,000 BOE/day.
Operating costs remained steady at $19.10 per BOE for Q2, within the guided $18-$20 per BOE range, though Q3 OpEx is expected to rise temporarily due to expensed production enhancement activities.
First oil at Blackrod was achieved ahead of schedule and on budget, a notable operational milestone.
Operating cash flow for Q2 was $67 million (with Brent averaging around $100/bbl), and free cash flow turned positive at $4 million—the first positive quarter since 2023.
However, full-year free cash flow guidance remains cautious at $10 million to $110 million assuming $70 to $90 Brent, reflecting investor concerns about margin compression and slower cash flow growth despite higher commodity prices.

View recap

Gartner, Inc.

IT Q2 2026

Reported: 2026-08-06

Gartner’s Q2 results and outlook notably outperformed expectations, driving a 23% jump in the stock. Accelerating contract value growth, improved client engagement, and solid margin management underpinned confidence in the company’s Business and Technology Insights transformation and sustained demand for AI-related services.

Key takeaways

Contract value growth accelerated in Q2, supported by mid-single-digit growth with midsized enterprise clients across both GTS and GBS segments.
Client engagement rose 140 basis points year-over-year, with digital engagement up over 110 bps and human interactions increasing more than 150 bps.
Wallet retention improved sequentially as downsell activity stabilized, reflecting stronger customer loyalty across key segments, including government accounts.
Return on invested capital remained robust at 31%, while free cash flow generation remained strong, enabling continued shareholder returns.
Gartner reiterated confidence in delivering adjusted EPS CAGR above 12% over the next three years, driven by continued BTI transformation and expanding AI advisory demand.

View recap

Jacobs Engineering Group Inc.

J Q3 2026

Reported: 2026-08-06

Jacobs delivered results that beat expectations, as evidenced by a +4.3% stock reaction, driven by strong revenue growth, record backlog expansion, and continued margin improvement.

Key takeaways

Adjusted EPS rose 14% year-over-year to $1.84, supported by more than 8% organic adjusted net revenue growth.
Segment I&AF posted $2.1 billion in net revenue, marking a 10% increase and a quarterly record.
Adjusted EBITDA margin expanded by over 100 basis points year-over-year to 15.2%.
Backlog increased 27% to a record $29 billion, with a trailing 12-month book-to-bill ratio of 1.4x, signaling strong future revenue visibility.
The company raised full-year 2026 guidance for the third consecutive time, reflecting confidence in ongoing business momentum, including a growing AI infrastructure pipeline now representing 11% of adjusted net revenue.

View recap

Koc Holding AS

KCHOL.IS Q2 2026

Reported: 2026-08-06

The stock rose 4.7% reflecting better-than-expected profitability driven by significant net income growth, particularly from the Energy segment, and ongoing portfolio optimization initiatives that support the company’s strategic positioning and financial resilience.

Key takeaways

Consolidated net income surged 147% year-on-year to TRY 20.3 billion, supported by a 154% increase in profit before taxes to TRY 84 billion.
Energy segment was the primary profit driver, contributing TRY 20.7 billion—more than four times the comparable period last year—on strong operational performance amid volatile markets.
Automotive and Finance segments also posted positive contributions of TRY 3.4 billion and TRY 2.2 billion, respectively; Consumer Durables added TRY 421 million, mainly from one-time gains.
The holding level reported a net cash position of approximately $1 billion with comfortable liquidity metrics and conservative leverage (net debt/EBITDA of 1.1x), underpinning financial stability.
Active portfolio management included key acquisitions, stake monetizations, and strategic restructuring across subsidiaries, enhancing focus and scale while preserving capital discipline.

View recap

Kimco Realty Corporation

KIM Q2 2026

Reported: 2026-08-06

Kimco Realty’s shares declined 2.1% following its Q2 report as investors digested a cautious tone in the outlook despite solid operational results, reflecting some reservations about growth sustainability and margin pressures.

Key takeaways

FFO per diluted share rose 4.5% year-over-year to $0.46, supported by 3.5% same-property NOI growth driven by higher minimum rents and net recoveries.
Occupancy remained robust with small shop occupancy reaching a record 92.9% and overall portfolio occupancy steady at 96.4%, despite a modest 16-basis-point impact from a tenant bankruptcy.
Leasing momentum continues, signing 461 leases covering 2.5 million square feet with a 13.1% blended rent spread, and new leasing spreads hitting 40.4% for 161 new leases.
Capital recycling remains active with asset sales and two Florida acquisitions using 1031 exchange proceeds, underscoring disciplined portfolio management.
Despite raising the midpoint of full-year guidance and a 12% dividend increase, market reaction suggests investor caution over the sustainability of growth and possible margin headwinds ahead.

View recap

Kratos Defense & Security Solutions, Inc.

KTOS Q2 2026

Reported: 2026-08-06

Shares of Kratos Defense & Security Solutions gained 12.5% following earnings, driven by strong bookings, robust organic growth, and confident margin expansion despite foreign exchange headwinds.

Key takeaways

Last 12-month bookings totaled $1.99 billion with a book-to-bill ratio of 1.3:1, signaling continued demand strength and an expanding pipeline now valued at $15 billion.
Organic revenue growth was 19.1% year-over-year in Q2, with full-year 2026 organic growth guidance raised to 19%-23%.
EBITDA margins are improving and expected to continue expanding into 2027, supported by scaling production and operating leverage, even as the strong shekel weighs on Israeli operations profitability.
New contract wins include hypersonic programs Kraken 1 & 2, Nemesis, a $160 million directed energy counter-UAS system, and a $100 million space domain awareness system, highlighting broad defense market penetration.
Supply chain orders for 3,000 small turbojet engines ahead of 2027 production and progress on BladeWorks turbofan program position the engine segment for meaningful growth.

View recap

Lucid Group Inc. Common Stock

LCID Q2 2026

Reported: 2026-08-06

Lucid’s shares dropped 13% after the quarter due to a cautious outlook and ongoing operational challenges highlighted by the new CEO. Investor disappointment centers on continued margin compression and cash burn despite measures to reduce costs and adjust production, undermining confidence in near-term execution.

Key takeaways

CEO Silvio Napoli outlined a significant restructuring including a 20% workforce reduction and elimination of the second shift, targeting $115 million in annualized savings.
Production was intentionally reduced to better align with demand and improve working capital, indicating delivery deceleration.
A $1.4 billion cash flow improvement plan for 2026 was announced, but the company remains focused on cutting cash burn amid strained liquidity.
Operational issues persist, including past product launches before readiness, slow quality issue responses, and underinvestment in service, contributing to lost customer and investor trust.
The cautious tone and admitted execution shortfalls appear to have overshadowed any positives from cost savings and ongoing projects, driving the negative market reaction.

View recap

Lindblad Expeditions Holdings, Inc.

LIND Q2 2026

Reported: 2026-08-06

Lindblad Expeditions’ shares jumped 15.2% as revenue growth and margin expansion notably outperformed expectations, with management also raising revenue and net yield guidance for 2026.

Key takeaways

Total company revenue rose 19% year-over-year to $199 million, driven by a 16% increase in the Lindblad segment and 23% growth in Land Experiences.
Adjusted EBITDA increased 31% to $32.5 million, with margins improving 150 basis points to 16.3% despite fuel price pressures.
Occupancy reached 91%, surpassing the company’s 90% target and marking the highest second-quarter occupancy rate in a decade.
Net yield grew 4% to $1,294 per guest night, setting a second-quarter record for the sixth consecutive quarter.
Raised 2026 revenue guidance to $830-$860 million from $800-$850 million and increased net yield guidance by 50 basis points; full-year adjusted EBITDA guidance was reaffirmed.

View recap

Stride, Inc.

LRN Q4 2026

Reported: 2026-08-06

Stride’s shares rose 3.1% following the earnings announcement, reflecting optimism around leadership changes and stable enrollment and revenue growth despite mixed early enrollment signals.

Key takeaways

Enrollment increased 4.2%, with revenue growth of 4.7%, underpinning steady top-line expansion.
Management noted early application trends for the upcoming school year are slightly behind last year, though improved conversion rates and re-registration activity provide some offset.
The loss of the Roscoe Independent School District contract in Texas represents a localized setback, but the company maintains a strong presence across the state.
The new CEO, appointed immediately, brings a combined background in education and technology with a focus on improving student outcomes and expanding product offerings.
Fiscal discipline continues as a priority, with plans to consider opportunistic share repurchases after the next trading window opens.

View recap

Lattice Semiconductor Corporation

LSCC Q2 2026

Reported: 2026-08-06

Lattice Semiconductor's shares crept up just 0.9% following Q2 results that delivered solid growth but did not materially surpass investor expectations amid cautious upside signal from the market.

Key takeaways

Q2 revenue hit a record $201 million, up 18% sequentially and 62% year-over-year, driven by strength in Compute and Communications and Industrial and Embedded markets.
Compute and Communications revenue grew 18% sequentially and 83% year-over-year, supported by AI data center demand and expanding FPGA attach rates.
Industrial and Embedded revenue increased 17% sequentially and 36% year-over-year, benefiting from recovery in sectors including aerospace, defense, and robotics.
Non-GAAP EPS rose over 120% year-over-year to $0.53, reflecting operational leverage and margin expansion.
Q3 guidance anticipates $220 million in FPGA revenue (+65% year-over-year) and total revenue of $255 million including two months of AMI acquisition contribution, targeting an annualized $1 billion run rate with EPS guidance at $0.56.

View recap

Marriott International, Inc.

MAR Q2 2026

Reported: 2026-08-06

Marriott’s shares fell 7.4% following the quarter, reflecting investor disappointment primarily with the lowered full-year net rooms growth outlook due to construction delays and continued challenges in the Middle East impacting international RevPAR.

Key takeaways

Global RevPAR rose 3.4% in Q2, driven by strong growth in U.S. and Canada (+5%) and resilience in Europe (+4%), offset by a 43% decline in Middle East RevPAR amid ongoing conflict.
U.S. and Canada leisure RevPAR grew 7%, led by luxury and select service segments, while business transient segments showed more modest increases (2–3%).
Full-year 2026 global RevPAR guidance raised to 3.0%–3.5%, but net rooms growth guidance lowered to the low end of 4.5%–5% range due to Middle East construction delays and higher expected room deletions.
Margin management focused on owner economics through reduced loyalty charge-out rates (~5% cut), enhanced owner reimbursements, streamlined brand standards, and planned incentive programs tied to guest satisfaction.
Key wins include new long-term co-branded credit card agreements boosting loyalty ecosystem value and continued rollout of AI-powered technology enhancements for guest experience and operational efficiency.

View recap

McDonald's Corporation

MCD Q2 2026

Reported: 2026-08-06

McDonald’s shares rose 3.3% as system-wide sales growth and global comparable sales slightly exceeded expectations, driven by new unit openings and strong international execution. However, U.S. comparable sales growth was below target due to inconsistent execution and weaker marketing effectiveness.

Key takeaways

System-wide sales grew 4% in constant currency; global comparable sales grew 1.3%, with positive comps across all segments.
U.S. comparable sales grew only 0.8% in Q2, below internal expectations, hindered by inconsistent restaurant execution and lower consumer awareness of new value offerings.
New $3 Every Day Affordable Price (EDAP) and $4 Breakfast Meal Deal menus faced rollout challenges, dampening traffic incrementality.
Marketing programs did not meet expectations, and digital offer pullbacks impacted visits from loyal customers.
International markets continued solid execution with strong innovation, marketing, and value offerings supporting broadly stable results.

View recap

Merck & Co., Inc.

MRK Q2 2026

Reported: 2026-08-06

Merck’s Q2 results prompted a muted market reaction, reflecting balanced execution with steady revenue growth but no clear upside to alter expectations significantly.

Key takeaways

Reported revenue reached $16.6 billion, supported by continued strength in Oncology and Animal Health segments.
Recent product launches contributed incremental growth alongside sustained momentum from the KEYTRUDA oncology franchise.
Several clinical and regulatory milestones were achieved, including FDA approval of LIPFENDRA, the first oral PCSK9 inhibitor.
The company completed the acquisition of Terns Pharmaceuticals, bolstering its hematology pipeline with a promising late-stage asset.
Management reaffirmed confidence in the full-year outlook and long-term growth strategy, though the market showed limited enthusiasm.

View recap

New Jersey Resources Corporation

NJR Q3 2026

Reported: 2026-08-06

Shares fell 4.6% as investors reacted negatively to increased capital spending and cautious execution, which pressured near-term financial metrics despite management’s positive framing.

Key takeaways

Fiscal Q3 net financial earnings (NFE) rose to $11.3 million ($0.11 per share), up from $6.2 million ($0.06) in the same quarter last year, supported by higher Clean Energy Ventures (CEV) earnings and favorable Storage & Transportation (S&T) recontracting.
Guidance was narrowed and midpoint increased to $3.52-$3.62 per share for fiscal 2026, reflecting greater full-year visibility, though underlying caution remains.
Capital expenditures were raised to a new range of $815 million to $950 million, up from $775 million to $930 million, driven by safety, reliability, and infrastructure investments at New Jersey Natural Gas (NJNG).
While S&T received a key FERC certificate ahead of schedule for Leaf River expansion, the benefits are longer-term and do not offset near-term margin pressures.
The market appeared concerned about margin compression risk and the elevated spending profile weighing on near-term returns despite ongoing project progress.

View recap

ONEOK, Inc.

OKE Q2 2026

Reported: 2026-08-06

ONEOK shares declined 1.1% following the quarter, reflecting investor caution despite management's raised guidance and volume growth, likely due to concerns over margin trends or cautious long-term execution risks rather than top-line momentum.

Key takeaways

Q2 net income was $967 million, or $1.53 per diluted share, up 13% year-over-year.
Adjusted EBITDA reached $2.12 billion, a 7% increase supported by volume growth and strong segment performance.
Raised 2026 financial guidance for the second time, with net income midpoint at $3.6 billion and adjusted EBITDA at $8.35 billion.
Capital expenditure guidance remains $2.7-3.2 billion, with spending expected to accelerate in H2 as large projects near completion.
Management highlighted operational execution and expanding processing capacity in the Permian Basin, with new projects coming online through 2027.

View recap

ON Semiconductor Corporation

ON Q2 2026

Reported: 2026-08-06

Shares declined 4.3% after earnings due to cautious outlook signals and uneven execution despite some growth areas, with investors likely disappointed by signs of deceleration and margin pressure hinted in the commentary.

Key takeaways

Revenue reached $1.6 billion with a non-GAAP gross margin of 39.3% and diluted EPS of $0.74, all stated above midpoint guidance but insufficient to offset investor concerns.
AI data center remains the fastest-growing segment, with silicon carbide revenue expected to grow nearly 60% in 2026, reflecting strong demand and expanded customer wins.
Automotive revenue in China grew 13% year-over-year in H1 2026 despite a 4% decline in vehicle sales, driven by increased content per vehicle and market share gains.
Energy storage system (ESS) revenue expected to rise 40% in 2026, supported by new product introductions such as the 99.3% efficiency EliteSiC hybrid ESS module.
While leadership emphasized expanding roles and product innovation, the cautious tone and absence of clear upward guidance revisions likely pressured the stock amid ongoing market skepticism.

View recap

Opendoor Technologies Inc.

OPEN Q2 2026

Reported: 2026-08-06

Opendoor’s shares fell 4.6% following earnings as the market reacted negatively to margin compression and a cautious outlook, despite solid volume growth. Investors appear concerned about the seasonal decline in contribution margins and the temporary drag from the Doma acquisition integration.

Key takeaways

Weekly signed contracts reached a multi-year high of around 700, over 5x year-over-year growth, indicating strong top-line volume.
Contribution margins improved quarter-over-quarter and reached the company’s target range, bolstered by improved seller conversion rates without sacrificing pricing.
The remaining 100 homes from the legacy Opendoor 1.0 era continue to drag margins but are expected to be sold mostly this quarter, closing that chapter.
Management warned of a seasonal margin decline heading into Q3, exacerbated by the Doma acquisition integration which is a temporary margin headwind.
The outlook suggests Q4 margins may improve, potentially reversing historical seasonal trends, but the cautious tone and margin pressure weighed on investor sentiment.

View recap

Public Service Enterprise Group Incorporated

PEG Q2 2026

Reported: 2026-08-06

Shares declined 1.4% following the Q2 report as investors digested modest growth amid ongoing regulatory uncertainties and rate case timing, with no clear catalysts to drive the stock higher.

Key takeaways

Reported non-GAAP operating earnings of $0.86 per share for Q2, bringing first-half operating earnings to $2.41 per share, in line with management’s reaffirmed full-year guidance of $4.28 to $4.40 per share.
PSE&G’s system investments and increased nuclear and gas operations offset the concluded Zero Emission Certificate program, supporting stable financial results but without acceleration.
Significant storm restoration efforts during the quarter highlighted operational resilience but underscored ongoing infrastructure challenges and regulatory scrutiny with a forthcoming BPU review.
Regulatory developments remain a watchpoint: the upcoming base rate case anticipated by year-end 2026 and participation in ongoing BPU proceedings may pressure near-term rate adjustments and earnings visibility.
Transmission cost improvements via PJM filings provide a modest benefit (~$33 million expected for H2 2026), yet the broader regulatory environment and affordability mandates temper optimism.

View recap

Pfizer Inc.

PFE Q2 2026

Reported: 2026-08-06

Pfizer’s shares rose 3.1% following Q2 2026 results, driven primarily by raised revenue guidance and strong growth in acquired product portfolios, signaling investor approval of the company’s strategic execution and pipeline progress.

Key takeaways

Raised full-year 2026 revenue guidance midpoint, while reaffirming adjusted diluted EPS guidance.
Acquired product revenues grew 25% operationally year-over-year, excluding prior year’s one-time items.
Legacy Seagen U.S. portfolio advanced with 21% year-over-year revenue growth, adjusting for onetime stocking.
Pipeline progress includes 3 regulatory approvals, 6 key data readouts, and 8 pivotal study starts in first half of 2026.
Cost savings initiatives updated with an additional $1 billion from realignment and $3 billion total expected from manufacturing optimization through 2029.

View recap

The Progressive Corporation

PGR Q2 2026

Reported: 2026-08-06

Progressive’s shares inched up modestly by 1.1% after earnings, reflecting a market view that results were largely in line with expectations without clear surprises to drive a stronger move.

Key takeaways

Progressive achieved the milestone of becoming the largest U.S. personal auto writer based on direct premiums written over the past 12 months.
Nearly 25% of U.S. households now hold at least one Personal Lines protection product from Progressive, underlining broad market penetration.
The company continues to focus on four strategic pillars: people and culture, broad needs, leading brand, and competitive prices to drive profitable growth.
Emphasis remains on serving targeted customer segments (Sam, Diane, Wright, Robinsons) with tailored products, despite most share gains coming from the less bundled segments.
Management highlighted ongoing efforts to grow bundled home and auto offerings, but no specific guidance changes or margin commentary was provided.

View recap

Pinterest, Inc.

PINS Q2 2026

Reported: 2026-08-06

Pinterest's stock dropped 3.3% after Q2 earnings, driven by investor disappointment over a cautious outlook and signs of revenue growth deceleration despite ongoing user expansion and AI investments.

Key takeaways

Monthly active users increased to 640 million, with 4% growth in the core UCAN market and continued strong traction among Gen Z, now more than half the user base.
Revenue grew 18% globally but showed signs of slowing momentum compared to earlier accelerated growth rates.
AI integration continues to expand, powering personalization and a new conversational shopping assistant aimed at converting inspiration into purchases.
Management highlighted cost efficiencies from leveraging open source AI models, reducing transaction costs to less than 8% of comparable proprietary models.
Despite progress, cautious language around monetization pacing and future guidance weighed on sentiment, reflecting investor concerns about sustaining revenue growth and margin improvement.

View recap

Powell Industries, Inc.

POWL Q3 2026

Reported: 2026-08-06

Shares fell 5.2% after earnings as investors reacted to signs of margin pressure and a cautious outlook, overshadowing a record backlog and strong order intake.

Key takeaways

New orders hit a record $934 million in Q3, nearly triple year-ago levels, driven notably by a $400 million mega data center project.
Backlog surpassed $2.4 billion, the highest in company history, providing extended visibility into fiscal 2028.
Third quarter revenue grew 9% year-over-year, led by industrial, oil and gas, and electric utility markets.
Gross margin narrowed to 30.6%, signaling margin compression despite productivity efforts.
Management emphasized cautious capital deployment and a conservative M&A approach due to elevated valuations.

View recap

Qualys, Inc.

QLYS Q2 2026

Reported: 2026-08-06

Qualys’ stock jumped 18.3% following the earnings release, reflecting investor approval of its advancements in AI-driven cybersecurity solutions that significantly accelerate vulnerability detection and autonomous remediation.

Key takeaways

Introduced Agent Insta, enabling near-instant detection of new vulnerabilities without traditional scanning delays, collapsing detection timelines from days to minutes.
Launched autonomous zero-day remediation powered by AI, with rollback rates below 1.5%, automating patch deployment across multi-vendor environments and reducing exposure windows from 21 days to minutes.
Enhanced TruRisk Management platform capabilities, integrating detection, validation, prioritization, and remediation into a continuous closed loop that addresses the surge in exploitable vulnerabilities in real time.
Expanded AI security coverage with TotalAI 2.0, offering visibility into AI usage and risks across enterprise workloads, employees, and SaaS platforms including Anthropic and OpenAI.
Customer conversations increasingly driven by demand for AI-native risk operations, positioning Qualys well to capitalize on the accelerating threat landscape.

View recap

Rockwell Automation, Inc.

ROK Q3 2026

Reported: 2026-08-06

Rockwell Automation shares dropped 6.4% after Q3 results as investors focused on cautious outlook signals, slowing organic recurring revenue growth, and softer-than-expected Lifecycle Services performance, despite solid product sales and margin expansion.

Key takeaways

Reported sales grew 8% year-over-year, with organic sales up 10%, though impacted by Sensia dissolution (-3%) and modest currency tailwind (+1%).
Software & Control organic sales surged 18%, driven by strong growth in Logix, while Lifecycle Services sales declined 2%, constrained by weak capital spending in Food & Beverage and process industries.
Organic annual recurring revenue rose only 6%, missing expectations and weighed down by slower growth in recurring Lifecycle Services.
Enterprise operating margin expanded to 22.3%, supported by higher volume and favorable mix; adjusted EPS was $3.49, up double digits from prior year.
End markets remain mixed with strength in Semiconductor, Data Center, and E-commerce & Warehouse Automation; however, capex recovery in Food & Beverage and parts of process industries remains absent, keeping the outlook cautious.

View recap

Revolve Group, Inc.

RVLV Q2 2026

Reported: 2026-08-06

The stock declined 2.8% following Q2 results as margin gains from tariff refunds were offset by elevated logistics costs and substantial investments weighing on operating expenses, leading to mixed investor sentiment despite solid sales growth.

Key takeaways

Net sales increased 12% year-over-year to $347 million, marking the third consecutive quarter of double-digit growth.
Gross margin improved to 56.6%, boosted by a 160 basis point tailwind from IEEPA tariff refunds; excluding these, margin rose roughly 90 basis points driven by AI-optimized markdowns.
Operating expenses grew significantly, reflecting strategic investments in long-term initiatives including marketing and development of new product lines and physical retail.
Elevated logistics costs, especially internationally, impacted profitability due to geopolitical-driven fuel surcharges and freight increases.
Net income was $19 million and diluted EPS stood at $0.26, benefiting from tariff refunds but facing pressure from higher expenses.

View recap

RH

RYTM Q2 2026

Reported: 2026-08-06

Rhythm Pharmaceuticals’ shares rose 7.7% following the quarter, driven by a promising start to the U.S. launch of IMCIVREE for acquired hypothalamic obesity (HO) and encouraging early clinical data for its next-generation MC4R agonist, RM-718.

Key takeaways

Since FDA approval in March, over 400 start forms have been received from roughly 300 prescribers for IMCIVREE in HO, indicating strong early demand.
Published Phase III HO TRANSCEND trial results and accompanying New England Journal of Medicine editorial have raised disease awareness and credibility of IMCIVREE among clinicians and payers.
RM-718 Phase II open-label data show a meaningful mean BMI reduction of 11.6% at 16 weeks in HO patients, with a favorable tolerability profile and no generalized hyperpigmentation reported.
Two patients discontinued RM-718 early due to injection site reactions and nausea; overall patient retention remains solid with 8 of 11 enrolled still on therapy.
Rhythm is progressing toward anticipated regulatory submissions and launches in Japan and Europe, leveraging an established rare disease commercial platform.

View recap

Space Exploration Technologies Corp.

SPCX Q2 2026

Reported: 2026-08-06

SpaceX shares declined 5.5% following the earnings release, primarily due to cautious commentary on future execution risks and a lack of concrete near-term guidance, which tempered investor enthusiasm despite strong revenue growth and adjusted EBITDA gains.

Key takeaways

Q2 revenue soared 92% year-over-year to $7.8 billion, driven by Falcon launch services and expanding Starlink operations.
Adjusted EBITDA surged 191% to $3.5 billion, reflecting improved scale and operational leverage.
The company reported a net loss of $541 million, though this marked a $467 million improvement from the prior-year quarter.
Management highlighted ambitious long-term growth targets for payload capacity (up to 10 million tons/year with Starship) and Starlink bandwidth expansion, but offered limited clarity on near-term execution and monetization milestones.
Momentum in AI capabilities with Grok 4.5 and upcoming versions underlined strategic investments, but there was no detailed guidance on how these will impact financial results.

View recap

Strata Critical Medical, Inc.

SRTA Q2 2026

Reported: 2026-08-06

The stock gained 5.4% after reporting better-than-expected growth in the clinical business, driven by strong 23.8% sequential growth in Transplant Clinical revenue and expanding gross margins, which outweighed softness in the Logistics segment.

Key takeaways

Clinical revenue increased 15.1% sequentially on an organic basis, fueled by 23.8% growth in Transplant Clinical services.
Clinical gross margins improved to 26.1% in Q2 from 25% in Q1, enhancing overall profitability.
Logistics revenue faced headwinds due to significantly reduced flying volumes with one nonexclusive customer, impacting about 3% of segment revenue; volume reduction expected to impact full Q3 before recovery.
Operating cash flow was $5.7 million with free cash flow of $2.9 million, marking the second consecutive quarter of positive cash generation.
Closed three bolt-on acquisitions expanding clinical capabilities and geographic reach, strengthening future growth and margin profile while advancing capital deployment ahead of plan.

View recap

SSR Mining Inc.

SSRM Q2 2026

Reported: 2026-08-06

The 7.4% stock rise reflects investor approval of SSR Mining’s focused repositioning after divesting Turkish assets and the sizable cash proceeds strengthening its balance sheet. Market enthusiasm centers on the company’s commitment to capital returns and anticipated growth in U.S. production despite elevated sustaining costs.

Key takeaways

Q2 production was 102,000 gold equivalent ounces with all-in sustaining costs of $26.22/oz, in line with expectations but trending toward the high end of guidance.
Divestments of Çöpler and Hod Maden generated approximately $1.5 billion in cash, boosting SSR’s cash balance to nearly $1.8 billion and resulting in zero debt.
Returned $400 million to shareholders year-to-date through dividends and buybacks, implying an ~8% yield before upcoming payouts.
Increased growth capital expenditures signal a strategic pivot to extend mine life and enhance asset quality in the Americas.
Production expected to ramp in the second half, weighted 55–60% to that period, supporting full-year guidance and free cash flow generation despite higher fuel and sustaining costs.

View recap

TKO Group Holdings, Inc.

TKO Q2 2026

Reported: 2026-08-06

TKO's shares gained 1.5% in reaction to the Q2 results, reflecting a market response that was cautiously receptive but not exuberant. While marquee live events and audience metrics underscored the company's operational momentum, the modest market move suggests that investors saw room for further proof on sustained profitability and execution across segments.

Key takeaways

UFC Freedom 250 delivered significant exposure with 34 million viewers and $1 billion in earned media value, fueling brand strength.
UFC events posted record-setting grosses in multiple venues, including the highest grossing event in UFC and venue histories.
WWE maintained strong fan engagement with sold-out events across North America, Europe, and the Middle East, spotlighting demand resilience.
On Location’s hospitality business supported the record-breaking FIFA World Cup, positioning it well for future large-scale global events.
Management expressed confidence with an upward revision to full-year guidance, although the stock’s moderate gain implies investor caution on margin or growth sustainability.

View recap

TransMedics Group, Inc.

TMDX Q2 2026

Reported: 2026-08-06

Shares fell 6.2% as investors reacted negatively to cautious growth outlook and heavy investment weighing on near-term operating leverage despite solid revenue gains.

Key takeaways

Total revenue reached approximately $190 million, up 21% year-over-year and 9% sequentially, driven by broad-based growth across product and service lines.
Transplant product revenue increased 16% year-over-year to $111 million, with liver cases up 28% and heart cases up 6% annually.
Logistics revenue, a key differentiator, grew 39% year-over-year to $41 million, reflecting expanded air transport coverage and improved operational efficiency.
Adjusted income from operations stood at roughly $25.8 million (14% margin), but management emphasized prioritizing growth investments over near-term leverage.
The company doubled down on expansion with a strategic investment in PAD Aviation, aiming to build a European transplant logistics network, signaling further near-term capital deployment.

View recap

Toast, Inc.

TOST Q2 2026

Reported: 2026-08-06

The stock rose 6.1% following earnings, driven primarily by stronger-than-expected growth in recurring gross profit streams and accelerated customer additions, underscoring investor confidence in the company’s AI-driven product expansion and scalable platform momentum.

Key takeaways

Recurring gross profit streams grew over 28% year-over-year, illustrating continued strength in core profitability metrics.
GAAP operating income margin expanded to 26%, reflecting improved operating leverage despite ongoing investments.
Net location adds hit a record 9,500, exceeding prior quarterly highs and signaling sustained customer acquisition momentum.
New AI-powered product, Toast IQ Grow, is rapidly gaining traction and is on track to be the fastest-growing product to $10 million ARR; early client results include a 70% reduction in agency spend and over $100,000 in marketing-attributed sales in ~2 months.
Expansion across new verticals such as gas stations and endorsement by major hospitality brands like Best Western supports growth beyond traditional restaurant segments.

View recap

Travis Perkins plc

TPK.L Q2 2026

Reported: 2026-08-06

Shares rallied 16.3% following results that showed meaningful margin expansion and improved cash generation, signaling investor relief amid persistent revenue headwinds and cautious trading conditions.

Key takeaways

Revenue declined 1.8% to £2.258 billion, with like-for-like sales down 0.7%, reflecting weak market demand and the sale of Staircraft; new housebuilding activity remains stalled.
Gross margin expanded by 100 basis points due to successful pricing actions, a favorable sales mix shift away from low-margin transactions, and rigorous category management efforts.
Adjusted operating profit increased 6.3% to £67 million, aided by property profits and margin improvement, while adjusted EPS grew 13.5% to 15.1p.
Net cash position improved substantially to £55 million from a £103 million net debt position year-over-year, underscoring strong cash discipline despite challenging market conditions.
Market conditions remain uncertain, with construction output impacted by weather and economic headwinds, and the company is conservatively managing risk by avoiding low-margin deals and diligently monitoring credit exposure.

View recap

Tower Semiconductor Ltd.

TSEM Q2 2026

Reported: 2026-08-06

Tower Semiconductor's shares dropped 9.9% post-earnings as investors reacted negatively to a cautious outlook and deceleration signals despite record margins and revenue growth, signaling skepticism about sustainability and guidance credibility.

Key takeaways

Q2 2026 revenue reached $460 million with record gross (30%), operating (20%), and net margins (20%), driven by increased revenue flow-through.
CEO highlighted accelerated revenue growth and margin expansion as part of a longer-term profitability model targeting $3.6 billion revenue and 45% gross margin by 2028.
The company announced a strategic dual-track 300mm capacity expansion in Japan, with full production readiness expected by Q4 2027, aiming to serve AI and data center markets.
Silicon photonics revenue surged over 60% quarter-over-quarter and 270% year-over-year, achieving a $680 million annualized run rate heading toward a $1 billion target by Q4 2026.
Despite growth, market reaction reflects concerns around the pace of execution, sustainability of margin gains, and the cautious tone on future quarters, outweighing operational achievements.

View recap

Versigent PLC

VGNT Q2 2026

Reported: 2026-08-06

Versigent’s shares rose 7.1% following Q2 results that notably beat expectations on bookings and commercial momentum, reflecting investor approval of sustained volume growth and strategic capital return initiatives.

Key takeaways

New awards totaled over $2.8 billion in Q2, underlining strong bookings expansion.
Launched 39 large-scale global programs supporting 22 customers, with >99% quality and on-time delivery.
Extended engineering and manufacturing expertise into commercial vehicle, agricultural, and battery energy storage markets, though these adjacent efforts remain early stage and are not included in current guidance.
Announced initiation of a quarterly dividend alongside a $250 million share repurchase authorization, signaling disciplined capital allocation and confidence in cash flow durability.
Continued focus on operational excellence and supply chain resilience supports competitive positioning amid increasing complexity and demand.

View recap

Viemed Healthcare, Inc.

VMD Q2 2026

Reported: 2026-08-06

Viemed Healthcare’s stock declined 16% post-earnings as investors reacted negatively to a cautious outlook and operational challenges masked by record revenue growth. Despite topline expansion, margin pressures and a heavy operational lift from sales reorganizations raised concerns about near-term profitability and scalability.

Key takeaways

Q2 revenue reached a record $78.1 million, up 24% year-over-year and 4% sequentially.
Ventilator rental revenue grew 8% year-over-year to $36.4 million but now represents a smaller share (47%) of total revenue compared to prior year (54%).
Equipment sales nearly doubled to $19 million, driven by growth in sleep resupply and maternal health lines.
Ongoing sales organization restructuring created significant operational headwinds, emphasizing a heavy operational lift with unclear short-term return prospects.
Management highlighted steady patient growth under the new CMS coverage framework but remained cautious on the pace of sustainable margin expansion and the fragmented outlook for the remainder of the year.

View recap

5N Plus Inc.

VNP.TO Q2 2026

Reported: 2026-08-06

Shares dropped 8.3% following Q2 results as investors reacted negatively to margin compression driven by higher input costs and operational inefficiencies, coupled with a cautious outlook amid ongoing geopolitical risks and cost pressures.

Key takeaways

Revenue rose 28% year-over-year to $122.4 million in Q2 and 30% year-to-date to $240.3 million, supported by strong demand in renewable energy and space markets.
Adjusted EBITDA increased 10% to $26.6 million in Q2 and 24% year-to-date to $55.8 million, though margin expansion was constrained.
Gross margin percentage declined to 30.3% in Q2 from 34.6% a year ago due to elevated metal input costs, higher chemical prices, and temporary operational inefficiencies during capacity ramp-up.
Specialty Semiconductors segment faced unplanned equipment maintenance, contributing to operational disruption and incremental expenses despite solid demand.
Management emphasized ongoing geopolitical uncertainties and inflationary pressures, maintaining a prudent outlook and focusing on productivity and capacity expansion amid elevated costs.

View recap

Voyager Technologies, Inc.

VOYG Q2 2026

Reported: 2026-08-06

Voyager's shares surged 36.5% following a well-received quarter driven by record revenue, bookings, and backlog, alongside an upward revision to full-year revenue guidance supported by the Astrobotic acquisition.

Key takeaways

Q2 revenue hit a record $53 million, up 51% sequentially as programs transitioned into production.
Bookings accelerated to a record $113 million, pushing backlog to $336 million, signaling strong demand and visibility into 2026 and 2027.
Full-year 2026 revenue guidance increased to a range of $275 million to $305 million, representing approximately 66% to 84% growth.
Acquisition of Astrobotic expands Voyager’s exposure across the lunar economy with expected 2026 revenue contribution of $40–50 million and potential synergies.
Growth driven by broad-based demand across multiple technology platforms, including propulsion, AI-enabled systems, and space infrastructure.

View recap

Wayfair Inc.

W Q2 2026

Reported: 2026-08-06

Wayfair’s Q2 2026 results impressed investors with accelerating growth in key segments, driving a 20.4% stock rally. Strength was led by a notable beat in top-line momentum, particularly from the U.S. segment and the high-growth luxury brand Perigold.

Key takeaways

Net revenue grew 7.5% year-over-year, fueled by a 6% increase in orders during the quarter and over 12% sequential growth from Q1.
U.S. revenue accelerated to nearly 9% growth, the best post-COVID performance, underpinned by specialty retail brands (+20%) and Perigold (+35%) gains.
Perigold now generates over $400 million annually, growing double-digit year-over-year with expanding margins despite investments in new store openings and brand marketing.
Active customers grew more than 3% overall, with Perigold’s active customer base rising nearly 20%, providing a higher-spending and more affluent cohort.
The relaunch of Perigold’s trade program contributed to an all-time high share of B2B volume, supporting sustainable expansion in this segment.

View recap

Xometry Inc. Class A Common Stock

XMTR Q2 2026

Reported: 2026-08-06

Xometry's shares rose 6.1% following Q2 results, reflecting investor approval of accelerating revenue growth and improved adjusted EBITDA driven by AI enhancements and broad-based marketplace strength.

Key takeaways

Q2 revenue increased 41% year-over-year to $229 million, marking the fourth consecutive quarter of accelerating growth.
Marketplace revenue growth accelerated to 45%, supported by stronger conversion rates and increased buyer adoption.
Adjusted EBITDA improved by $10.2 million year-over-year, reaching $14.1 million.
Management highlighted successful AI model upgrades enhancing costing, sourcing, and process recommendations, which underpin marketplace expansion.
Continued momentum led to an upward revision of guidance for H2 2026, signaling confidence in sustained compounding growth and operating leverage.

View recap

Zebra Technologies Corporation

ZBRA Q2 2026

Reported: 2026-08-06

Zebra’s shares gained 26.5% following a quarter that materially surpassed expectations, driven by broad-based growth, margin expansion, and a raised full-year outlook, signaling strong investor confidence in the sustainability of demand and profitability.

Key takeaways

Revenue surpassed $1.5 billion, up over 20% year-over-year, with 9% organic growth excluding acquisitions.
Adjusted EBITDA margin expanded to 27.7%, including $73 million tariff recovery; excluding tariffs, margin still improved by 2 points on stronger gross margins and operating leverage.
Non-GAAP EPS rose 76% year-over-year to $6.35, reflecting both improved profitability and operating efficiency.
Retail, manufacturing, and healthcare end markets all delivered strong double-digit growth; healthcare was the highest growth segment.
The company raised full-year guidance based on sustained demand and margin momentum, supported by large deal pipeline visibility into 2027.

View recap

Earnings Recaps

ADTRAN, Inc.

AdaptHealth Corp.

Astera Labs, Inc. Common Stock

Advanced Micro Devices, Inc.

AMETEK, Inc.

Amgen Inc.

Arista Networks, Inc.

Angel Oak Mortgage, Inc.

Apollo Global Management, Inc.

Avista Corporation

BB Seguridade Participacoes S.A.

BellRing Brands, Inc.

Black Stone Minerals, L.P.

BWX Technologies, Inc.

Certara, Inc.

Cipher Mining Inc. Common Stock

The Clorox Company

Cummins Inc.

Coupang, Inc.

Capital Southwest Corporation

Crexendo, Inc.

Danaos Corporation

3D Systems Corporation

DigitalOcean Holdings, Inc.

Domino's Pizza Group plc

Duke Energy Corporation

DaVita Inc.

Emerson Electric Co.

Enlight Renewable Energy Ltd

Fidelity National Information Services, Inc.

Fresenius Medical Care AG & Co. KGaA

Fresnillo plc

Gulfport Energy Corporation Common Shares

Green Thumb Industries Inc.

W.W. Grainger, Inc.

Hamilton Lane Incorporated

Harmony Biosciences Holdings, Inc.

HSBC Holdings plc

IDEXX Laboratories, Inc.

Inspire Medical Systems, Inc.

Intapp Inc. Common Stock

International Petroleum Corporation

Gartner, Inc.

Jacobs Engineering Group Inc.

Koc Holding AS

Kimco Realty Corporation

Kratos Defense & Security Solutions, Inc.

Lucid Group Inc. Common Stock

Lindblad Expeditions Holdings, Inc.

Stride, Inc.

Lattice Semiconductor Corporation

Marriott International, Inc.

McDonald's Corporation

Merck & Co., Inc.

New Jersey Resources Corporation

ONEOK, Inc.

ON Semiconductor Corporation

Opendoor Technologies Inc.

Public Service Enterprise Group Incorporated

Pfizer Inc.

The Progressive Corporation

Pinterest, Inc.

Powell Industries, Inc.

Qualys, Inc.

Rockwell Automation, Inc.

Revolve Group, Inc.

RH

Space Exploration Technologies Corp.

Strata Critical Medical, Inc.

SSR Mining Inc.

TKO Group Holdings, Inc.

TransMedics Group, Inc.

Toast, Inc.

Travis Perkins plc

Tower Semiconductor Ltd.

Versigent PLC

Viemed Healthcare, Inc.

5N Plus Inc.

Voyager Technologies, Inc.